Ownership

Kevin D. Freeman - Director at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: GALT on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Kevin D. Freeman - trading volume in the past year for Galectin Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+16.3K	100%	$2.69	+$43.8K
Sells
Net	+16.3K	100%		+$43.8K

Holdings reported by Kevin D. Freeman for Galectin Therapeutics Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	80K	$211K	$2.64	Oct 17, 2024	By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC
Common Stock	34.8K	$91.8K	$2.64	Oct 17, 2024	Direct
Common Stock	18.1K	$47.7K	$2.64	Oct 17, 2024	IRA
Stock Option (right to buy)	50K			Jan 24, 2024	Direct	Common Stock

Transactions reported by Kevin D. Freeman for Galectin Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.